MDA5   

Questions discussed in this category


Any indications for triple therapy in the patients with subclinical ILD associated with MDA-5 dermatomyositis?

Cyclophosphamide/tacrolimus and Rituximab have been used in conjunction with steroids in case series.


Papers discussed in this category


N Engl J Med,